Layer, Chiang, et al. Genome Biology
In Ongoing Suit, Alnylam Claims Partner Tekmira Misappropriated Trade Secrets
Alnylam charged Tekmira with wrongly using trade secrets to bolster its own drug delivery technology-development efforts and to file a patent application on Alnylam's phase I liver cancer drug.
New to GenomeWeb? Register here quickly.